Ensitrelvir

Chemical compound

Ensitrelvir, sold under the brand name Xocova, is an antiviral medication used as a treatment for COVID-19 and as post-exposure prophylaxis (PEP) to prevent COVID-19 infections following exposure. It was developed by Shionogi in partnership with Hokkaido University and acts as an orally active 3C-like protease inhibitor.

Nº Q110798570 ★★

Poco común · Saberes

Ensitrelvir

Chemical compound

Texto en inglés

Ensitrelvir, sold under the brand name Xocova, is an antiviral medication used as a treatment for COVID-19 and as post-exposure prophylaxis (PEP) to prevent COVID-19 infections following exposure. It was developed by Shionogi in partnership with Hokkaido University and acts as an orally active 3C-like protease inhibitor.

Último precio

—

Precio mínimo

—

Mediana 7 d

—

Ventas 30 d

0

Rango 30 d

—

En circulación

0

Cotización

Ver tabla
Fechamediana MínMáxventas

Historial de ventas

Última venta
—
Media 30 d
—
Mínimo 30 d
—
Máximo 30 d
—
Ventas 7 d
0
Ventas 30 d
0

Aún no hay ventas.

Ventas anónimas: sin comprador ni vendedor. Las cifras solo cuentan ventas entre jugadores.

En Wikipedia

Texto en inglés Aún no hay artículo en tu idioma: extracto en inglés.

Ensitrelvir, sold under the brand name Xocova, is an antiviral medication used as a treatment for COVID-19 and as post-exposure prophylaxis (PEP) to prevent COVID-19 infections following exposure. It was developed by Shionogi in partnership with Hokkaido University and acts as an orally active 3C-like protease inhibitor. It is taken by mouth. The most common adverse events include transient decreases in high-density lipoprotein and increased blood triglycerides.

Texto: Wikipedia en inglés, CC BY-SA 4.0. · Imagen: User:Innerstream (Public domain) ·

Cartas cercanas

Ver la ficha

Confirmación